Search results
Results from the WOW.Com Content Network
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
The Medical CBRN (Chemical, Biological, Radiological and Nuclear) Defense Consortium, a DOD initiative within its Joint Program Executive Office for Chemical and Biological Defense has awarded the company US$20 million to develop an auto-injector to administer diazepam.
Assistant Secretary of Defense (Nuclear, Chemical & Biological Defense Programs) Andrew C. Weber: January 7, 2011 – October 1, 2014: Robert M. Gates Leon Panetta Chuck Hagel: Barack Obama: Dr. A Thomas Hopkins (Acting) October 1, 2014 – November 29, 2017 Ash Carter: Barack Obama: Guy B. Roberts: November 30, 2017 – April 2, 2019: Jim ...
Meanwhile, the average defense stock today has an EV/S of 2.2 and a P/S of 1.8. ... Relative to its 15.4% long-term expected earnings growth rate and its 1% dividend yield, that gives the stock a ...
Ology Bioservices (previously named Nanotherapeutics, Inc.) is a private, American biopharmaceutical company headquartered in Alachua, Florida.The company was founded with research in nanometer-scale particle technology to develop new drug delivery technologies and increase the efficacy of existing drugs. [3]
For premium support please call: 800-290-4726 more ways to reach us
Following a 20% drop in share price over the last month, here's what makes Cintas a magnificent S&P 500 dividend stock to consider buying in 2025. Cintas: Leading its niche, but plenty of growth ...
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) [1] is a sub-office of the ASA(ALT).. The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense is the Joint Service’s lead for development, acquisition, fielding and life-cycle support of chemical, biological, radiological and nuclear defense equipment ...